BioVaxys Technology Corp. (BVAXF)
OTCMKTS
· Delayed Price · Currency is USD
0.0234
-0.0017 (-7.26%)
May 7, 2025, 2:44 PM EDT
BioVaxys Technology Statistics
Total Valuation
BVAXF has a market cap or net worth of 5.86 million. The enterprise value is 5.79 million.
Market Cap | 5.86M |
Enterprise Value | 5.79M |
Important Dates
The next estimated earnings date is Friday, June 27, 2025.
Earnings Date | Jun 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +58.48% |
Shares Change (QoQ) | +8.11% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 257.88M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -4.86 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.51 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.42
Current Ratio | 0.42 |
Quick Ratio | 0.21 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -177.53% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 224.70% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.34% in the last 52 weeks. The beta is -0.14, so BVAXF's price volatility has been lower than the market average.
Beta (5Y) | -0.14 |
52-Week Price Change | -60.34% |
50-Day Moving Average | 0.03 |
200-Day Moving Average | 0.04 |
Relative Strength Index (RSI) | 40.62 |
Average Volume (20 Days) | 1,619,773 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -2.71M |
Pretax Income | -3.83M |
Net Income | -3.83M |
EBITDA | n/a |
EBIT | -2.71M |
Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 108,764 in cash and 46,790 in debt, giving a net cash position of 61,974.
Cash & Cash Equivalents | 108,764 |
Total Debt | 46,790 |
Net Cash | 61,974 |
Net Cash Per Share | n/a |
Equity (Book Value) | -1.20M |
Book Value Per Share | -0.00 |
Working Capital | -1.20M |
Cash Flow
Operating Cash Flow | -1.91M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BVAXF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -58.48% |
Shareholder Yield | -58.48% |
Earnings Yield | -65.39% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |